Herbalife Ltd. (HLF 69.16, +0.99, +1.45%) announced the launch of Prolessa(TM) Duo, a stimulant free, dual-action, weight management product aimed at reducing hunger and promoting weight loss.* It's designed to be used as a booster with the company's flagship Formula 1 Protein Shake for the U.S. market.
Prolessa(TM) Duo powder provides a sense of fullness and prolonged satiety. The name refers to a proprietary blend of ingredients that have been shown individually in several human clinical studies to increase satiety by triggering the body's natural appetite control mechanisms, the ileal brake. The ileal brake is a physiologic mechanism that controls appetite and food intake, and helps suppress hunger. The fat reduction ingredients are designed to help one lose fat while increasing lean body mass, and lowering BMI.*
All Herbalife products are available exclusively through independent Herbalife distributors. Suggested retail price $ 24.95 for 7-day supply; $94.95 for 30-day supply.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat or prevent any disease.
Herbalife Ltd. (HLF 69.16, +0.99, +1.45%) is a global network marketing company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in 74 countries through a network of approximately 2 million independent distributors. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains a significant amount of information about Herbalife, including financial and other information for investors at ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.